Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$0.34 - $0.56 $1,170 - $1,928
-3,444 Reduced 88.26%
458 $0
Q1 2023

May 12, 2023

SELL
$0.32 - $1.54 $5,116 - $24,623
-15,989 Reduced 80.38%
3,902 $1,000
Q4 2022

Feb 08, 2023

BUY
$0.26 - $0.56 $3,920 - $8,443
15,077 Added 313.19%
19,891 $5,000
Q3 2022

Nov 10, 2022

BUY
$0.16 - $1.0 $636 - $3,977
3,977 Added 475.15%
4,814 $3,000
Q2 2022

Aug 10, 2022

SELL
N/A
-1,038 Reduced 55.36%
837 $1,000
Q1 2022

May 16, 2022

BUY
N/A
1,875 New
1,875 $3,000
Q4 2021

Feb 14, 2022

SELL
N/A
-2,711 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
N/A
2,711 New
2,711 $10,000

About SeqLL, Inc.


  • Ticker SQL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 11,886,400
  • Market Cap $47.5M
  • Description
  • SeqLL Inc. operates as a life sciences instrumentation and research services company worldwide. The company designs, develops, and manufactures genetic analysis technologies. It offers true single molecule sequencing (tSMS) platform, which offers a single molecule solution for DNA and RNA sequencing. The company has a collaboration agreement wit...
More about SQL
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.